Journal of Clinical Biochemistry and Nutrition · 2014 · 41 citations · 21 references
MedicineOncologyPharmacologyCarcinogenesisMolecular OncologyNeoplasiaColorectal CancerInflammation-associated CarcinogenesisColorectal Carcinogenesis PathophysiologyCyclooxygenase PathwaysCyclooxygenase-2 PathwayIndoleamine 2, 3-Dioxygenase PathwayProstaglandin Biosynthesis InhibitorsProstaglandin E2 BiosynthesisProstaglandin ProductionSuppression
Excessive prostaglandin production by cyclooxygenase-2 in stromal and epithelial cells is a causative factor of colorectal carcinogenesis. Thus, compounds which inhibit cyclooxygenase-2 transcriptional activity in colon epithelial cells could be candidates for anti-carcinogenic agents. A cyclooxygenase-2 transcriptional activity in the human colon cancer cell line DLD-1 has been measured using a β-galactosidase reporter gene system. Using this system, we demonstrated that the decrease in basal cyclooxygenase-2 transcriptional activities at 100 µM sesamol, one of the lignans in sesame seeds, was 50%. Other compounds in sesame seeds such as sesamin, sesamolin, ferulic acid, and syringic acid did not exhibit significant suppression of cyclooxygenase-2 transcriptional activity at up to 100 µM. In a following experiment, 6-week-old male Min mice, Apc-deficient mice, were divided into a non-treated and 500 ppm sesamol groups. At the age of 15 weeks, it was found that treatment with sesamol decreased the number of polyps in the middle part of small intestine to 66.1% of the untreated value. Moreover, sesamol suppressed cyclooxygenase-2 and cytosolic prostaglandin E2 synthase mRNA in the polyp parts. The present findings may demonstrate the novel anti-carcinogenetic property of sesamol, and imply that agents that can suppress cyclooxygenase-2 expression may be useful cancer chemopreventive agents.
21
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Michihiro Mutoh, Kouji Watanabe, Tomohiro Kitamura et al. · PubMed · 2002 · 369 citations
Medicine, Oncology, Pharmacology +10
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
Kouji Watanabe, Toshihiko Kawamori, Seiichi Nakatsugi et al. · PubMed · 1999 · 358 citations
Medicine, Oncology, Pharmacology +12